We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$9.68B
AUM Growth
+$282M
Cap. Flow
+$368M
Cap. Flow %
3.8%
Top 10 Hldgs %
10.65%
Holding
2,698
New
807
Increased
606
Reduced
561
Closed
588

Sector Composition

Rank Sector Weight
1 Financials 27.55%
2 Technology 14.73%
3 Healthcare 8.47%
4 Consumer Discretionary 7.67%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOL
1576
DELISTED
Emeren Group
SOL
$276K ﹤0.01%
+41,900
New +$301K
UNF icon
1577
Unifirst Corp
UNF
$5.25B
$276K ﹤0.01%
1,300
ROVR
1578
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$276K ﹤0.01%
+20,356
New +$251K
OCFC icon
1579
OceanFirst Financial
OCFC
$1.91B
$275K ﹤0.01%
12,800
-200
-2% -$4.1K
PLTK icon
1580
Playtika
PLTK
$1.12B
$275K ﹤0.01%
+9,936
New +$247K
AAON icon
1581
Aaon
AAON
$7.77B
$274K ﹤0.01%
6,300
-300
-5% -$13K
AIFU
1582
AIFU Inc
AIFU
$221M
$272K ﹤0.01%
57
+2
+4% +$11.1K
GMVD
1583
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$272K ﹤0.01%
3,474
+188
+6% +$19.8K
PRDS
1584
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$271K ﹤0.01%
+27,209
New +$270K
MSDA
1585
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
$271K ﹤0.01%
+27,677
New +$272K
INVZ icon
1586
Innoviz Technologies
INVZ
$112M
$270K ﹤0.01%
47,000
+35,300
+302% +$278K
SOC icon
1587
Sable Offshore Corp
SOC
$911M
$270K ﹤0.01%
+27,746
New +$268K
PRTA icon
1588
Prothena Corp
PRTA
$459M
$269K ﹤0.01%
+3,765
New +$234K
RUM icon
1589
RUM Group Inc
RUM
$1.76B
$268K ﹤0.01%
27,584
+1,842
+7% +$17.9K
VAQC
1590
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$268K ﹤0.01%
27,573
+16,273
+144% +$159K
REVEU
1591
DELISTED
Alpine Acquisition Corp Unit
REVEU
$268K ﹤0.01%
+26,449
New +$266K
GTES icon
1592
Gates Industrial Corporation Ltd.
GTES
$7.15B
$267K ﹤0.01%
+16,416
New +$281K
AXON
1593
Axon Enterprise
AXON
$46.4B
$266K ﹤0.01%
+1,521
New +$276K
IJR icon
1594
iShares Core S&P Small-Cap ETF
IJR
$112B
$266K ﹤0.01%
+2,438
New +$268K
CNR
1595
DELISTED
Cornerstone Building Brands, Inc.
CNR
$266K ﹤0.01%
+18,193
New +$296K
PRAX icon
1596
Praxis Precision Medicines
PRAX
$10.1B
$265K ﹤0.01%
+953
New +$259K
AMRC icon
1597
Ameresco
AMRC
$1.36B
$264K ﹤0.01%
+4,522
New +$298K
PINC
1598
DELISTED
Premier
PINC
$264K ﹤0.01%
+6,800
New +$251K
ATSG
1599
DELISTED
Air Transport Services Group
ATSG
$264K ﹤0.01%
10,216
+316
+3% +$7.97K
VLDR
1600
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$264K ﹤0.01%
+44,600
New +$335K

Similar funds

Schonfeld Strategic Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Schonfeld Strategic Advisors held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Schonfeld Strategic Advisors deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
  • Schonfeld Strategic Advisors added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
  • Schonfeld Strategic Advisors fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
  • Schonfeld Strategic Advisors opened 807 new positions and closed 588 in Q3 2021.
  • Schonfeld Strategic Advisors's portfolio value rose 3% quarter-over-quarter to $9.68B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.